Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
Ke‐Jia Wu, Pui-Man Lei, Hao Liu, et al.
Molecules (2019) Vol. 24, Iss. 24, pp. 4428-4428
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The role and potential of computer-aided drug discovery strategies in the discovery of novel antimicrobials
Samson O. Oselusi, Phumuzile Dube, Adeshina I. Odugbemi, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107927-107927
Open Access | Times Cited: 25
In silico Approaches for the Design and Optimization of Interfering Peptides Against Protein–Protein Interactions
Zahra Sadat Hashemi, Mahboubeh Zarei, Mohsen Karami Fath, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 73
Advancements in small molecule drug design: A structural perspective
Ke Wu, Eduard Karapetyan, John V. Schloss, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103730-103730
Open Access | Times Cited: 40
Computational approaches for the design of modulators targeting protein-protein interactions
Ashfaq Ur Rehman, Beenish Khurshid, Yasir Ali, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 315-333
Open Access | Times Cited: 35
Cobdock: an accurate and practical machine learning-based consensus blind docking method
Sadettin Yavuz Ugurlu, David W. McDonald, Huangshu Lei, et al.
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Yuqing Lu, Yuewen Yang, Guanghao Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3360-3382
Open Access | Times Cited: 14
An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge
Ugo Perricone, Maria Rita Gulotta, Jessica Lombino, et al.
MedChemComm (2018) Vol. 9, Iss. 6, pp. 920-936
Open Access | Times Cited: 40
Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Yuran Qiu, Xinyi Li, Xinheng He, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112764-112764
Closed Access | Times Cited: 35
Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far
Ahmed Elwakeel
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 19
Identifying NovelSARS-Cov-2 Inhibitors Using a Structure-Based Virtual Screening Approach
Loubna Taidi, Sokaina El Khamlichi, Amal Maurady
Lecture notes in networks and systems (2025), pp. 165-175
Closed Access
Pocket2Drug: An Encoder-Decoder Deep Neural Network for the Target-Based Drug Design
Wentao Shi, Manali Singha, Gopal Srivastava, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators
Sergio Algar, Mercedes Martín‐Martínez, Rosario González‐Muñiz
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113015-113015
Open Access | Times Cited: 18
Interfering with S100B–effector protein interactions for cancer therapy
Ke‐Jia Wu, Wanhe Wang, Huimin Wang, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 9, pp. 1754-1761
Closed Access | Times Cited: 16
In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer
Mohammed J. AL-Zobaidy, Hany Akeel Al-Hussaniy, Zahraa S. Al-tameemi
F1000Research (2024) Vol. 11, pp. 516-516
Open Access | Times Cited: 1
The AAA+ ATPase p97 as a novel parasite and tuberculosis drug target
George Kobakhidze, Ashish Sethi, Sepideh Valimehr, et al.
Trends in Parasitology (2022) Vol. 38, Iss. 7, pp. 572-590
Closed Access | Times Cited: 5
Review of Modern Computer-aided Drug Design Methods
Yipeng Lin
International Journal of Biology and Life Sciences (2022) Vol. 1, Iss. 1, pp. 47-50
Open Access | Times Cited: 5
Targeting the Integrated Stress Response Kinase GCN2 to Modulate Retroviral Integration
Chloé Torres, Asja Garling, Saı̈d Taouji, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5423-5423
Open Access | Times Cited: 6
Virtual Screening Process: A Guide in Modern Drug Designing
Umesh Panwar, Murali Aarthy, Mohammad Aqueel Khan, et al.
Methods in molecular biology (2023), pp. 21-31
Closed Access | Times Cited: 2
Design, synthesis, and evaluation of peptide‐imidazo[1,2‐a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525
James R. Sayer, K. Wallden, Hans Koss, et al.
Journal of Peptide Science (2021) Vol. 27, Iss. 10
Open Access | Times Cited: 5
Identification and characterization of new putative antimicrobial peptides from scorpion Chaerilus tricostatus revealed by in silico analysis and structure modeling
Marzieh Rostaminejad, Amir Savardashtaki, Mojtaba Mortazavi, et al.
Animal Gene (2022) Vol. 26, pp. 200137-200137
Closed Access | Times Cited: 3
In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer
Hany Akeel Al-Hussaniy, Zahraa S. Al-tameemi, Mohammed J. AL-Zobaidy
F1000Research (2022) Vol. 11, pp. 516-516
Open Access | Times Cited: 3
TECHNIQUES AND ALGORITHMS FOR STRUCTURE-BASED VIRTUAL SCREENING (SBVS): AN OVERVIEW
Raksha K. Rao, Somdatta Y. Chaudhari, Shailaja B. Jadhav, et al.
INDIAN DRUGS (2024) Vol. 61, Iss. 01, pp. 7-17
Closed Access
Virtual Tools and Screening Designs for Drug Discovery and New Drug Development
Sonal Dubey
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 108-134
Closed Access
General Strategies for Rational Design and Discovery of Multitarget Drugs
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 677-736
Closed Access | Times Cited: 2
In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer
Hany Akeel Al-Hussaniy, Zahraa S. Al-tameemi, Mohammed J. AL-Zobaidy
F1000Research (2022) Vol. 11, pp. 516-516
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top